Question

Mention the awards won by Richard Ebright.

Answer 1

Explanation:

Awards & Honors

• Searle Scholar Award, 1989
• Johnson & Johnson Discovery Research Fellow, 1990
• American Society for Biochemistry and Molecular Biology/Schering-Plough Research Achievement Award, 1995
• Walter J. Johnson Prize, 1995
• American Academy of Microbiology Fellow, 1996
• Howard Hughes Medical Institute Investigator, 1997
• Rutgers University Board of Trustees Research Excellence Award, 1998
• American Association for the Advancement of Science Fellow, 2004
• Infectious Diseases Society of America Fellow, 2011
• Theobald Smith Society Waksman Award, 2012
• National Institutes of Health MERIT Award, 2013
• Ameican Academy of Arts and Sciences Member, 2016
• Rutgers University Chancellors Award for for Research Excellence, 2017.

FOLLOW ME....

Answer 2

Answer:

Ebright was appointed as a faculty member in the Department of Chemistry at Rutgers University and as a Laboratory Director at the Waksman Institute of Microbiology in 1987.[1] He was co-appointed as an Investigator of the Howard Hughes Medical Institute from 1997 to 2013.[1]

Ebright has performed research on protein-DNA interaction,[3][4][5]transcription initiation,[6][7][8][9][10][11][12]transcription activation,[13][14][15][16][17][18] transcription-translation coupling,[19] and antibacterial drug discovery.[20][21][22][23][24][25] Ebright's research results include the experimental demonstration that amino-acid-base contacts mediate DNA sequence recognition in protein–DNA interaction,[3] the determination of the three-dimensional structural organization of the transcription initiation complex;[6][7][10][11] the demonstration that transcription start-site selection and initial transcription involve a "DNA scrunching" mechanism;[8][9][12] the demonstration that transcription activation can proceed by a "recruitment" mechanism;[13][14][15][17][18] the demonstration that bacterial transcription-translation coupling involves direct physical bridging of RNA polymerase and a ribosome by NusA and NusG[19]; and the identification of novel antibacterial drug targets in bacterial RNA polymerase.[20][21][22][23][24][25]